For instance, EGFR mediated the efficacy of CAP in killing EGFR-overexpressing oral squamous cell carcinoma cells [132] and the expression of death receptors such as TNFR1 and DR4/5 were noticeably enhanced in glioblastoma cells after CAP treatment [133]. Here, EGFR is linked to glioblastoma.